These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11748435)

  • 1. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
    Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
    Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
    Sergieva SB; Timcheva KV; Hadjiolov ND
    J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
    Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
    Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
    Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
    Del Vecchio S; Zannetti A; Aloj L; Caracò C; Ciarmiello A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):879-87. PubMed ID: 12721767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
    Del Vecchio S; Zannetti A; Ciarmiello A; Aloj L; Caracò C; Fonti R; Botti G; D'Aiuto G; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):809-14. PubMed ID: 12029556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Detection of Multidrug-Resistance Related Proteins in Locally Advanced Breast Cancer Using 99mTc-MIBI SPECT/CT Imaging: Correlation with Clinical Outcomes.
    Mostafa NM; Elnaggar MS; Abdelhafez YG; Rezk K; Sherif MF; Eltyb HA; Ahmed S; Abu Elnga NE; Hussien MT
    Asian Pac J Cancer Prev; 2024 Sep; 25(9):3125-3141. PubMed ID: 39342592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic imaging: scintimammography.
    Salvatore M; Del Vecchio S
    Eur J Radiol; 1998 May; 27 Suppl 2():S259-64. PubMed ID: 9652532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
    Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
    Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
    Zaman MU; Nasir Z; Raza T; Hashmi H; Hashmi A; Fatima N
    J Coll Physicians Surg Pak; 2009 Mar; 19(3):173-8. PubMed ID: 19268018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
    Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
    Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators.
    Uğur Y; Sari O; Uğur O; Korkusuz P; Varoğlu E; Arslan N; Gürcan N; Yildirim M; Sökmensüer C; Aşan E; Aras T
    Ann Nucl Med; 2003 Jun; 17(4):281-7. PubMed ID: 12932110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
    Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
    Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
    Zhang XM; Zhang ZW; Wu H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
    Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
    Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.